US Patent Issued to Enanta Pharmaceuticals on Nov. 4 for "Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,923, issued on Nov. 4, was assigned to Enanta Pharmaceuticals Inc. (Watertown, Mass.).

"Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof" was invented by Guoqiang Wang (Belmont, Mass.), Ruichao Shen (Belmont, Mass.), Brett Granger (Sudbury, Mass.), Jing He (Somerville, Mass.), Xuechao Xing (Wilmington, Mass.), Yong He (Lexington, Mass.), Jiang Long (Wayland, Mass.), Jun Ma (Wayland, Mass.), Bin Wang (Newton, Mass.) and Yat Sun Or (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts and esters thereof...